FdaApplication
NDA 204017
Identifiers
- fda_app_no: NDA204017
Properties
| Property | Value |
|---|---|
| applicant_name | AGILE THERAPEUTICS INC |
| application_type | NDA |
| approval_date | 2020-02-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TWIRLA | ETHINYL ESTRADIOL; LEVONORGESTREL | 0.01MG/24HR;0.04MG/24HR | SYSTEM;TRANSDERMAL |
1 product